Related Experiment Video
Updated: Jun 20, 2026
12:17
Full-root Aortic Valve Replacement by Stentless Aortic Xenografts in Patients with Small Aortic Roots
Published on: May 21, 2017
Development of aortic valve implantation.
Nawwar Al-Attar1, Patrick Nataf
1Assistance Publique-Hôpitaux de Paris (AP-HP), Department of Cardiovascular Surgery, Bichat-Claude Bernard Hospital, University Paris 7 Denis Diderot, Paris, France.
Herz
|August 28, 2009
Summary
Severe symptomatic aortic stenosis management is evolving. Transcatheter aortic valve implantation offers new options for high-risk patients unsuitable for traditional surgery.
Area of Science:
- Cardiovascular Medicine
- Interventional Cardiology
- Public Health
Background:
- Aortic valve stenosis (AVS) is a significant public health concern in Europe, exacerbated by an aging population.
- Severe symptomatic AVS is typically managed with surgical aortic valve replacement (SAVR).
- Advances in perioperative care have enabled SAVR in high-risk individuals.
Purpose of the Study:
- To discuss the development and current state of transcatheter aortic valve implantation (TAVI) as an alternative to SAVR.
- To explore TAVI's role in managing patients with severe symptomatic AVS who are contraindicated for or at high risk with conventional surgery.
- To review available TAVI technologies, procedural approaches, and future directions.
Main Methods:
- Review of current literature and clinical data on transcatheter aortic valve implantation.
- Discussion of technological advancements in TAVI devices and delivery systems.
- Analysis of different TAVI procedural approaches (e.g., transfemoral, transapical).
Main Results:
- Transcatheter techniques, particularly TAVI, provide a viable therapeutic option for patients with severe symptomatic AVS who are poor surgical candidates.
- TAVI has expanded treatment possibilities, offering new hope for previously untreatable or high-risk patient groups.
- The field of TAVI is rapidly evolving with ongoing technological innovation and refinement of techniques.
Conclusions:
- Transcatheter aortic valve implantation represents a paradigm shift in managing severe symptomatic aortic valve stenosis.
- TAVI offers a less invasive alternative for patients at high risk or unsuitable for surgical valve replacement.
- Continued research and development in TAVI technology and patient selection will further optimize outcomes.
